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Abstract.  Macrophages undergo apoptosis after infected by Mycobacterium tuber-
culosis (M.tb), which is regulated by tumor necrosis factor α (TNF-α) and has a 
direct correlation with killing of intracellular bacilli. In order to clarify the role of 
isoniazid (INH) in the modulation of macrophages apoptosis and intracellular ba-
cilli replication, we performed the following studies using an INH-resistant clinical 
M.tb isolate (INHres). Macrophages derived from peripheral blood were infected 
with INHres and treated or not treated with INH. Apoptosis was measured using 
an Ag-capture ELISA for histone and fragmented DNA. Production of TNF-α by 
INHres infected was assayed using ELISA and viability of intracellular M.tb was 
determined using bacterial culture of macrophage lysates on Löwenstein-Jensen 
(LJ) medium. INH pre-treatment to INHres reduced macrophages apoptosis, 
production of TNF-α and intracellular INHres viability. This study indicated 
that INH affected TNF-α release resulting in reduction of the extent macrophages 
apoptosis and of intracellular INH-resistant M.tb viability.  
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(Takayama et al, 1972; Slayden and Barry, 
2000). Interestingly, defective mycolic acid 
synthesis in M. smegmatis is not associated 
with the lethal effect of INH on this mu-
tant strain (Liu and Nokaido, 1999). Thus 
it is an over simplification to believe that 
there is a single underlying mechanisms 
of M.tb killing by INH. Understanding 
the other targets of INH is very important 
to develop new strategies against INH-
resistant M.tb.
M.tb is able to live and replicate 
within macrophages. Tumor necrosis fac-
tor (TNF)-α is capable of supporting the 
growth of intracellular virulent but not the 
attenuated M.tb (Engele et al, 2002).  M.tb 
INTRODUCTION
Isoniazid (INH) is an effective most 
widely used anti-tuberculosis drugs 
which acts by interfering with nearly ev-
ery metabolic pathway in Mycobacterium 
tuberculosis (M.tb). However, accumulat-
ing data suggest that mycolic acid syn-
thesis is selectively inhibited by INH and 
is correlated with its lethal effect on M.tb 
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infection can induce human macrophage 
apoptosis (Danelishvili et al, 2003), which 
is regulated by the release of TNF-α (Patel 
et al, 2007) and has a direct correlation with 
the killing of intracellular bacilli (Oddo 
et al, 1998; Arcila et al, 2007). Macrophage 
apoptosis also is crucial for stimulating 
innate immunity against M.tb and eradi-
cation of intracellular M.tb. However, 
there is no satisfying explanation of the 
advantages of macrophage apoptosis for 
the infected host and the pathogen side 
effects that accrue. The latter phenomena 
may be a strategy for bacilli to overcome 
host defenses. On the other hand, the host 
might exploit apoptosis as a means to limit 
replication of intracellular pathogens.
INH modulates TNF α-induced apop-
tosis in murine macrophage cell line, which 
is a consequence of the metabolic blockade 
on M.tb by INH (Gil et al, 2003). In order to 
clarify the role of INH in the modulation 
of macrophage apoptosis and intracel-
lular bacilli viability, we examined these 
properties using an INH-resistant clinical 




M.tb clinical isolate was obtained 
from a patient in primary health care unit 
at a hospital in Yogyakarta, Indonesia. 
M.tb was identified using classical proce-
dures based on such parameters as rate of 
growth, colony morphology and pigmen-
tation, and also the biochemical properties 
(Wu et al, 2007).  Susceptibility of the M.tb 
clinical isolate to INH was tested using the 
agar proportional method on Lőwenstein-
Jensen (LJ) medium. One colony resistant 
to 1 µg ml-1 of INH INHres) was chosen. 
M.tb strain H37Rv was used as control. 
Macrophage cell culture
Peripheral blood mononuclear cells 
were isolated using standard gradient 
centrifugation method of Hystopaque® 
(Sigma, St Louis, MO) from heparin-
treated blood of healthy and non-smoker 
donors after informed consent was gran- 
ted. Mononuclear cells were suspended in 
RPMI 1640 medium supplemented with 
L-glutamine (300 µg/ml), without sodium 
bicarbonate (GIBCO, Gaithersburg, MD), 
10% fetal bovine serum (Invitrogen, Carls-
bad, CA), 10% L929 conditioned medium 
as source of macrophage colony-stimulat-
ing factor (M-CSF), penicillin (50 IU/ml) 
and streptomycin (50 µg/ml) (complete 
medium). The cells were incubated for 2 
hours at 37°C under an atmosphere con-
taining 5% CO2. Then, non adherent cells 
were removed by washing with RPMI 
1640 medium and the remaining adherent 
monocytes were collected and subjected 
to viability test and cell counting using 
trypan blue staining. Monocytes were 
suspended in complete medium, added 
to a 24-well plate at a concentration of 
5x105 cells ml-1 per well and incubated 
as describe above for 4 days, after which 
time cells were infected with M.tb.  Prior 
to infection the complete medium was re-
placed with incomplete medium (without 
antibiotics).
M.tb infection of macrophages
M.tb INHres and H37Rv isolates 
were grown on LJ medium and then were 
suspended in Ringer lactate solution, 
vortexed and homogenized by repeated 
passages through a 27G syringe (Stokes 
et al, 2004). INH (0.1 µg ml-1 and 1 µg 
ml-1) was added to the INHres suspen-
sion and incubated for 20 minutes, then 
the suspension was added to macrophage 
cell culture. Macrophages infected with 
INH-treated and untreated INHres and 
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also H37Rv M.tb isolates for 4 hours at 
multiplicity of infection (MOI) of 1 to 10. F 
Extracellular M.tb was removed by wash-
ing with RPMI 1640. MOI was measured 
by counting the intracellular M.tb after 
staining with AcriFluortm fluorescence dye.
Determination of apoptosis
M.tb-infected macrophages were 
incubated for 3 days as described above. 
Then, apoptosis was measured using 
an Ag-capture ELISA for histone and 
fragmented DNA (Cell Death Detection 
ELISAplus, Roche, Indianapolis, IN) in cell 
lysates and absorbance was measured at 
405 nm (Keane et al, 2000). Macrophage 
apoptosis also was confirmed by manu-
ally determining percent apoptotic cells 
after hematoxyline-eosin (HE) staining of 
parallel experiments. Cell counting was 
performed under a light microscope (400x 
magnification) for 300 fields.
Intracellular M.tb viability assay
Macrophages cell lysate used in the 
apoptosis measurements were applied to 
LJ medium and M.tb viability was mea-
sured (cfu ml-1) by counting the colonies 
present after 4 weeks incubation at 37°C.
Measurement of macrophage TNF-α pro-
duction 
M.tb.-infected macrophages were in-
cubated for 24 hours as described above 
and then TNF-α levels in the cell culture 
medium were measured using Tumour 
Necrosis Factor Alpha [(h)TNFα] Human 
Biotrak ELISA System (Amersham Biosci-
ences, San Diego, CA).
Statistical analysis
Analysis of variance (ANOVA) was 
used together with Tukey HSD analysis to 
differentiate the effect of INH treatment. 
RESULTS
INHres M.tb-infection of human mac-
rophages induced apoptosis, but this was 
attenuated nearly to uninfected (control) 
level when macrophages were infected 
with INH-treated INHres M.tb (Fig 1a). 
These findings were confirmed by manu-
ally counting of HE stained cells, showing 
a significant difference in apoptosis level 
between infection with INH-treated and 
untreated INHres M.tb (p< 0.05) (Fig 1b). 
In order to elucidate the mechanism 
by which INH treatment decreased 
apoptosis of INHres M.tb-infected mac-
rophages, production of TNF-α by such 
macrophages was investigated. No TNF-α 
was released from uninfected macro-
phages, but non INH treated INHres M.tb-
infected macrophages released 2.2-folds 
more TNF-α compared to that NH treated 
INHres M.tb-infected cells (Fig 2a). It 
is worth noting that TNF-α production 
from INHres M.tb-infected macrophages 
is significantly lower than that from cells 
infected with H37Rv M.tb (Fig 2a). 
The viability of intracellular INHres 
M.tb is significantly higher compared to 
that of intracellular H37Rv strain, but 
INH pre-treatment of INHres M.tb has 
no significant effect on the bacilli viability 
(Fig 2b). 
DISCUSSION
The level of apoptosis of macrophages 
infected with INH-sensitive M.tb H37Rv 
strain has been reported to be indistin-
guishable from those infected with INH 
resistant strains (Rachmawaty et al, 2006). 
In the current study, a clinical INHres M.tb 
isolate was treated directly with INH prior 
to macrophage infection in order to avoid 
the direct effect of INH on the macrophage 
function (Gil et al, 2003). Our findings 
demonstrated that INH pre-treatment 
resulted in reduction of the capability of 
intracellular INHres M.tb to induce mac-
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Fig 1–Apoptosis of M.tb-infected macrophages in culture. 
Macrophages cells were infected with H37Rv or INHres 
(untreated or pre-treated H with 0.1 µg ml-1 and 0.1 µg 
ml-1) at MOI 1:10 and incubated  at 37 °C under an atmo-
sphere containing 5% CO2 for 72 hours. Negative control 
macrophages were not infected with M.tb.  Apoptosis 
was determined using Cell Death Detection ELISAplus 
kit (Roche). Absorbance at 405 nm corresponds to the 
apoptosis level (a). Results are shown as mean ± SEM 
percent apoptosis of 5 independent experiments con-
ducted in duplicate. The data were collected from du-
plicate measurements of five independent experiments 
and showed as means with SEM. In addition, infected 
macrophages were fixed, stained with hematoxyline-
eosin and macrophages that underwent apoptosis were 
manually counted in 300 microscope fields (400x magni-
fication) (b). Results are shown as mean ± SEM percent 
apoptosis of 3 independent experiments conducted in 
duplicate observations. 
rophages apoptosis. The 
concentrations of INH used 
did not affect the viability of 
intracellular INHres M.tb. 
In any case, live M.tb (Ke-
ane et al, 1997; Placido et al, 
1997) and also killed M.tb 
are able to induced macro-
phage apoptosis (Klingler 
et al, 1997). However, there 
is a significant decrease in 
TNF-α production by the 
INH-treated compared to 
non treated INHres M.tb-
infected macrophages.
TNF-α is released by 
macrophages in response to 
either live or killed H37Rv 
M.tb (Lasco et al, 2003). A 
synthetic lipid-A like an-
tagonist showed an ability 
to block TNF-α production 
and leads to human alveo-
lar macrophage apoptosis 
arrest (Means et al, 2001). 
TNF-α production is crucial 
in mediating M.tb-induced 
macrophage apoptosis 
(Means et al, 2001). Injection 
of INH to mice has no direct 
effect on TNF-α production 
by monocytes (Urbascheck 
et al, 1991). There was a di-
rect correlation of percent 
macrophage apoptosis and 
TNF-α production (pg/ml) 
(r = 0.89; α = 0.05). Previous 
reports have indicated that 
apoptosis of macrophages 
leads to the intracellular 
M.tb elimination (Placido 
et al, 1997; Oddo et al, 1998). 
However, the induction 
of macrophage apoptosis 
by H2O2, ATP and stauro-
a
b
IsonIazId TreaTmenT of MycobacteriuM tuberculosis








INHres INHres + 1 INH H37Rv








































Fig 2–TNF-α production by M.tb-infected macrophage (a) and 
viability of intracellular M.tb (b).  Macrophages were 
infected with either INH (1 µg ml-1) pretreated INHres, 
untreated INHres or INHres M.tb strain, and incubated 
for 24 hours at 37ºC under an atmosphere containing 
5% CO2. TNF-α released into culture medium was mea-
sured using Tumour Necrosis Factor Alpha [(h)TNFα] 
Human Biotrak ELISA System (Amersham Biosciences). 
Results are shown as mean ± SEM of 3 independent 
experiments conducted in duplicate. Intracellular M.tb 
bacilli released from lyzed infected macrophages were 
grown on Lőwenstein-Jensen medium and colonies 
were counted after 4 weeks incubation at 37ºC.  Results 
are shown as mean ± SEM of 4 independent experiments 
conducted in duplicate observations.
sporine has no significant 
effect on mycobacterial vi-
ability (Pais and Appelberg, 
2004). TNF-α might support 
the growth of intracellular 
virulent but not attenuated 
M.tb (Engele et al, 2002). In 
addition, TNF-α antagonist is 
able to inhibit the replication 
of virulent M.tb (Haraguchi 
et al, 2006). 
Intracellular M.tb has the 
ability to multiply during 48 
hours in culture and the final 
intracellular M.tb population 
after 48 hours of incubation 
does not correspond to the 
MOI (Santucci et al, 2000). 
At low MOI, M.tb within 
macrophages replicates faster 
compare to the higher MOI, 
resulting in comparable num-
bers of intracellular M.tb 
after 48 hours. Similarly, our 
results showed that the vi-
ability of INH-treated intra-
cellular INHres M.tb is not 
significantly different from 
untreated bacilli, even though 
the numbers of viable M.tb 
may not have been the same 
at the time of inoculation. The 
release of cytokines, includ-
ing TNF-α, is a double-edged 
sword, contributing both 
to the protective immunity 
and the immunopathology 
of the tuberculosis. TNF-α 
antagonist treatment has been 
reported to activate latent 
tuberculosis (Carmona et al, 
2005), but on the other hand 
decreasing local TNF-α levels 
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tion (Engele et al, 2002). In this report 
we demonstrated another useful role of 
INH, instead of its mycobatericidal effect, 
it also is capable of inhibiting apoptosis 
and TNF-α production of INHres M.tb-
infected macrophage. 
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